CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-02 | Zakrzewski Joseph S Director | Option exercise | +35,000 | $1.35 | $47K | 469,547 |
| 2019-01-02 | Zakrzewski Joseph S Director | Sale | −385,000 | $13.03 | $5.0M | 84,547 |
| 2019-01-02 | Zakrzewski Joseph S Director | Option exercise · Stock Option (Right to Buy) | −350,000 | 700,000 | ||
| 2019-01-02 | Zakrzewski Joseph S Director | Option exercise · Stock Option (Right to Buy) | −35,000 | 0 | ||
| 2018-12-31 | Kennedy Joseph T General Counsel | Option exercise | +47,188 | 265,122 | ||
| 2018-12-31 | Kennedy Joseph T General Counsel | Option exercise | +6,250 | 271,372 | ||
| 2018-12-31 | Kennedy Joseph T General Counsel | Shares withheld for taxes | −26,495 | $13.24 | $351K | 244,877 |
| 2018-12-31 | Kennedy Joseph T General Counsel | Sale | −26,943 | $13.49 | $364K | 217,934 |
| 2018-12-31 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −47,188 | 94,374 | ||
| 2018-12-31 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −6,250 | 12,500 | ||
| 2018-12-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,604 | $1.40 | $4K | 343,901 |
| 2018-12-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +4,167 | $2.50 | $10K | 348,068 |
| 2018-12-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +3,750 | $2.50 | $9K | 351,818 |
| 2018-12-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +3,750 | $2.50 | $9K | 355,568 |
| 2018-12-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,770 | $2.95 | $8K | 358,338 |
| 2018-12-31 | Ketchum Steven B Chief Scientific Officer | Sale | −17,041 | $13.51 | $230K | 341,297 |
| 2018-12-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,604 | 33,854 | ||
| 2018-12-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −4,167 | 24,998 | ||
| 2018-12-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,750 | 22,500 | ||
| 2018-12-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,750 | 52,938 |
Page 77 of 95 · 1,885 trades